Presence of a non-neuronal cholinergic system and occurrence of up- and down-regulation in expression of M2 muscarinic acetylcholine receptors: new aspects of importance regarding Achilles tendon tendinosis (tendinopathy)

被引:0
作者
Dennis Bjur
Patrik Danielson
Håkan Alfredson
Sture Forsgren
机构
[1] Umeå University,Department of Integrative Medical Biology, Section for Anatomy
[2] Umeå University,Department of Surgical and Perioperative Science, Sports Medicine
来源
Cell and Tissue Research | 2008年 / 331卷
关键词
Achilles tendon; Tendinosis; Innervation; Cholinergic; Muscarinic; Human;
D O I
暂无
中图分类号
学科分类号
摘要
Limited information is available concerning the existence of a cholinergic system in the human Achilles tendon. We have studied pain-free normal Achilles tendons and chronically painful Achilles tendinosis tendons with regard to immunohistochemical expression patterns of the M2 muscarinic acetylcholine receptor (M2R), choline acetyltransferase (ChAT), and vesicular acetylcholine transporter (VAChT). M2R immunoreactivity was detected in the walls of blood vessels. As evidenced via parallel staining for CD31 and alpha-smooth muscle actin, most M2R immunoreactivity was present in the endothelium. M2R immunoreactivity also occured in tenocytes, which regularly immunoreact for vimentin. The degree of M2R immunoreactivity was highly variable, tendinosis tendons that exhibit hypercellularity and hypervascularity showing the highest levels of immunostaining. Immunoreaction for ChAT and VAChT was detected in tenocytes in tendinosis specimens, particularly in aberrant cells. In situ hybridization revealed that mRNA for ChAT is present in tenocytes in tendinosis specimens. Our results suggest that autocrine/paracrine effects occur concerning the tenocytes in tendinosis. Up-regulation/down-regulation in the levels of M2R immunoreactivity possibly take place in tenocytes and blood vessel cells during the various stages of tendinosis. The presumed local production of acetylcholine (ACh), as evidenced by immunoreactivity for ChAT and VAChT and the detection of ChAT mRNA, appears to evolve in response to tendinosis. These observations are of importance because of the well-known vasoactive, trophic, and pain-modulating effects that ACh is known to have and do unexpectedly establish the presence of a non-neuronal cholinergic system in the Achilles tendon.
引用
收藏
页码:385 / 400
页数:15
相关论文
共 218 条
[1]  
Alfredson H(2002)Chronic tendon pain: no signs of chemical inflammation but high concentrations of the neurotransmitter glutamate. Implications for treatment? A review Curr Drug Targets 3 43-54
[2]  
Lorentzon R(2005)Sclerosing injections to areas of neo-vascularisation reduce pain in Achilles tendinopathy: a double-blind randomised controlled trial Knee Surg Sports Traumatol Arthrosc 13 338-344
[3]  
Alfredson H(2001)Glutamate NMDAR1 receptors localized to nerves in human Achilles tendons. Implications for treatment? Knee Surg Sports Traumatol Arthrosc 9 123-126
[4]  
Öhberg L(2003)Is vasculo-neural ingrowth the cause of pain in chronic Achilles tendinosis? An investigation using ultrasonography and colour Doppler, immunohistochemistry, and diagnostic injections Knee Surg Sports Traumatol Arthrosc 11 334-338
[5]  
Alfredson H(1995)Chronic Achilles tendinopathy. A survey of surgical and histopathologic findings Clin Orthop 316 51-164
[6]  
Forsgren S(1997)Distribution of muscarinic receptors on the endothelium of cortical vessels in the brain Brain Res 778 25-33
[7]  
Thorsen K(2005)The innervation pattern of the human Achilles tendon: studies of the normal and tendinosis tendon with markers for general and sensory innervation Cell Tissue Res 320 201-206
[8]  
Fahlström M(1994)New insights into the local regulation of blood flow by perivascular nerves and endothelium Br J Plast Surg 47 527-543
[9]  
Johansson H(2001)Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors Hepatology 33 148-158
[10]  
Lorentzon R(1998)International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors Pharmacol Rev 50 279-290